M.D. FORTE GLYCARE PERFECTION - salicylic acid gel 
Allergan, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Drug Facts

Active Ingredient

Salicylic Acid 1%

Purpose

Acne Treatment

Uses

Warnings

For external use only

Do not use

  • with other acne medications or if you are sensitive to salicylic acid.

When using this product

  • avoid unnecessay sun exposure and use sunscreen.
  • keep away from eyes, lips and mouth.
  • this product may cause irritation, characterized by redness, burning, itching, peeling or possible swelling.

More frequent use or higher concentrations may aggravate such irritation.

Stop use and ask a doctor if

  • condition worsens or does not improve after regular use.

Keep out of the reach of children.

  • If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

store at 20-25°C (68-77°F)

Inactive ingredients

water (agua), sd alcohol 40-b, glycolic acid (and) ammonium glycolate, hydroxypropyl methylcellulose

NDC 0023-9217-17

GLYCARE

PERFECTION

GEL

ACNE

MEDICATION

M.D. FORTÉ®

1.7 FL. OZ. (50ml)

Carton

M.D. FORTE GLYCARE PERFECTION 
salicylic acid gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0023-9217
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
salicylic acid (salicylic acid) salicylic acid10 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
water 
alcohol 
glycolic acid 
ammonia 
hypromellose 2208 (100 MPA.S) 
Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMultilevel Packaging
1NDC:0023-9217-171 TUBE (1 TUBE) in 1 CARTONcontains a TUBE
150 mL in 1 TUBEThis package is contained within the CARTON (0023-9217-17)

Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D02/04/199712/02/2012

Labeler - Allergan, Inc. (144796497)
Establishment
NameAddressID/FEIOperations
Ei, Inc.105803274MANUFACTURE

Revised: 11/2010 Allergan, Inc.